Nuvectis Pharma Inc. (NVCT): Price and Financial Metrics
NVCT Price/Volume Stats
| Current price | $9.49 | 52-week high | $11.80 |
| Prev. close | $9.24 | 52-week low | $4.44 |
| Day low | $9.19 | Volume | 62,194 |
| Day high | $9.60 | Avg. volume | 127,624 |
| 50-day MA | $9.05 | Dividend yield | N/A |
| 200-day MA | $7.09 | Market Cap | 198.28M |
NVCT Stock Price Chart Interactive Chart >
Nuvectis Pharma Inc. (NVCT) Company Bio
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product pipeline includes NXP800 and NXP900. The company was founded by Ron Bentsur, Enrique Poradosu and Shay Shemesh on July 27, 2020 and is headquartered in Fort Lee, NJ.
NVCT Price Returns
| 1-mo | -0.42% |
| 3-mo | 21.67% |
| 6-mo | 91.72% |
| 1-year | 42.71% |
| 3-year | -50.05% |
| 5-year | N/A |
| YTD | 75.42% |
| 2024 | -35.13% |
| 2023 | 11.20% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
Loading social stream, please wait...